Key facts
- This page summarizes Heather Ann McSharry's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 May 2026, 18:07.
Heather Ann McSharry - 22 May 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- Director
- Issuer ticker
- JAZZ
- Reported as of
- 22 May 2026
- Net transaction value
- -$482,000
- SEC form
- 4
- Accepted by SEC
- 27 May 2026, 18:07:06 UTC
- Prior SEC filing
- 24 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Paz Dizon, as attorney in fact For: Heather Ann McSharry
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Heather Ann McSharry filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 27 May 2026.
Change
- Previous filing in this sequence was filed on 24 Nov 2025.
- Current net transaction value: -$482,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001576068
Primary reporting owner
McSharry Heather Ann
- Relationship
- Director
- Address
- 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
- Signature
- By: /s/Paz Dizon, as attorney in fact For: Heather Ann McSharry
- Signature date
- 27 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Sale
- Transaction value
- $482,000
- Shares
- -2,000
- Change %
- -9.8%
- Price
- $241.00
- Shares after
- 18,449
- Date
- 22 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.